Background: To analyze the presence of burning mouth syndrome (BMS) in a group of patients diagnosed with oral lichenoid disease (OLD).
Material And Methods: A retrospective study of 217 patients diagnosed with OLD; 158 (72,8%) women and 59 (27,2%) men, with an average age upon diagnosis of 56,4 years (SD 11,88). We carried out a detailed and complete characterization of symptoms, with special emphasis on BMS diagnostic data specified by the International Headache Society.
Results: Four patients (1.8%) presented with long-term clinical symptoms of burning mouth, indicative of BMS and they fulfilled the IHS 2018 criteria, except for criterion D, i.e."Oral mucosa is of normal appearance". The observed lichenoid mucosal lesions were not considered to be able to account for the reported intraoral pain in any of our patients. Thus neither diagnosis was considered to be exclusive.
Conclusions: Patients diagnosed with OLD, and who simultaneously present clinical characteristics of BMS should be studied in detail, in order to evaluate the possibility of both diagnoses concurring.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7648912 | PMC |
| http://dx.doi.org/10.4317/medoral.23812 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Predictors of Dysplasia in Oral Submucous Fibrosis: A Retrospective Observational Study.
Cureus
February 2025
Department of Oral and Maxillofacial Pathology, Jawahar Medical Foundation's Annasaheb Chudaman Patil Memorial Dental College, Dhule, IND.
Introduction: Oral submucous fibrosis (OSMF) is a progressive, potentially malignant disorder often associated with areca nut and tobacco consumption. Dysplasia, a key predictor of malignant transformation, is poorly understood in terms of its association with clinical and histopathological factors. This study aimed to identify the clinical and histopathological predictors of dysplasia in OSMF to enhance diagnostic accuracy and risk stratification.
View Article and Find Full Text PDFColchicine in the Management of Oral Submucous Fibrosis - A Systematic Review and GRADE Assessment.
J Pharm Bioallied Sci
December 2024
Department of Preventive Dentistry, College of Dentistry, Jouf University, Sakaka, Saudi Arabia.
Background And Objectives: Oral submucous fibrosis (OSMF) is a chronic oral potentially malignant disorder affecting the oral mucosa. The habit of areca nut chewing is established to be the causative factor. Various treatment modalities are available for managing OSMF.
View Article and Find Full Text PDFVortioxetine SSRI/SNRI with Pregabalin Augmentation in Treatment-Resistant Burning Mouth Syndrome: A Prospective Clinical Trial.
Curr Neuropharmacol
February 2025
Department of Surgical, Medical and Health Sciences, University of Trieste, 447 Strada di Fiume, 34149, Trieste, Italy.
Objectives: The treatment of Burning Mouth Syndrome (BMS) represents a challenge in tailoring appropriate medication for individual patients. The augmentation of pregabalin to conventional treatment has shown promising outcomes in relieving pain and improving the quality of life in chronic pain conditions. This study aimed to compare the efficacy of vortioxetine with other antidepressants (SSRIs/SNRIs) in combination with pregabalin in a cohort of unresponsive BMS patients and to predict treatment response by using clinical data.
View Article and Find Full Text PDF[Accurate evaluation model of burning mouth syndrome based on inflammatory factors and psychological scores:a clinical study].
Zhonghua Kou Qiang Yi Xue Za Zhi
February 2025
Department of Oral Mucosal Diseases, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine & College of Stomatology, Shanghai Jiao Tong University & National Center for Stomatology & National Clinical Research Center for Oral Diseases & Shanghai Key Laboratory of Stomatology & Shanghai Research Institute of Stomatology, Shanghai 200011, China.
To explore the correlation between anxiety, depression, and inflammatory markers in the body fluids of patients with burning mouth syndrome (BMS), creating a preliminary assessment model based on clinical data. Forty-one BMS patients were recruited according to the predefined inclusion criteria and exclusion criteria from the Oral Mucosal Diseases Department at Shanghai Ninth People's Hospital between December 2021 and September 2023, along with 12 healthy controls. The pain intensity of the 41 patients was assessed using the visual analog scale (VAS).
View Article and Find Full Text PDFCommentary: The immediate pain relief of low-level laser therapy for burning mouth syndrome: a retrospective study of 94 cases.
Front Oral Health
February 2025
Department of Psychosomatic Dentistry, Graduate School of Medical and Dental Sciences, Institute of Science Tokyo, Tokyo, Japan.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!